固体瘤的TCR-T细胞疗法:挑战和新兴的解决方案
Wanjun He1,2, Kai Cui1,2, Muhammad Asad Farooq1
1Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, The First Dongguan Affiliated Hospital, School of Medical Technology, Guangdong Medical University, Dongguan, China.
Frontiers in pharmacology
|March 25, 2025
概括
T细胞受体T细胞 (TCR-T细胞) 显示出对固体瘤免疫疗法的希望,克服了CAR-T细胞的局限性. 将TCR-T疗法与其他策略相结合可能会提高抗瘤疗效和安全性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 包括CAR-T细胞在内的T细胞免疫疗法推进了癌症治疗,特别是血液性恶性瘤.
- 在固体瘤中,CAR-T细胞疗法面临着挑战,包括向,T细胞贩运和瘤微环境 (TME) 中的生存.
研究的目的:
- 在癌症治疗中审查TCR-T细胞的结构和功能.
- 概述TCR-T细胞治疗的局限性,并提出潜在的解决方案.
- 突出TCR-T细胞在治疗固体瘤中的潜力.
主要方法:
- 对T细胞受体T细胞 (TCR-T) 和仿真抗原受体T细胞 (CAR-T) 疗法的现有文献的综述.
- 对TCR-T细胞与CAR-T细胞在固体瘤治疗中的优势进行分析.
- 讨论在瘤微环境中增强TCR-T细胞疗效的策略.
主要成果:
- 与CAR-T细胞相比,TCR-T细胞具有卓越的指导能力,更广泛的抗原识别,并有可能准更广泛的蛋白质.
- 由于其固有的特性,TCR-T细胞可能为固体瘤免疫治疗提供更有效的方法.
- 涉及TCR-T疗法和其他新兴策略的组合方法对于最大限度地提高抗瘤活性和安全性至关重要.
结论:
- TCR-T细胞疗法为固体瘤治疗提供了一个有希望的替代方案,解决了CAR-T细胞的关键局限性.
- 进一步的研究和组合策略的开发对于优化固体瘤的TCR-T细胞疗法至关重要.
- 在TME中提高TCR-T细胞的疗效和确保治疗安全对于临床成功至关重要.
更多相关视频
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.1K
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
399
相关概念视频
01:27Tumor Immunotherapy
450
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K